Gesundheitswesen

Entscheidende Beratung auf Ihrem Weg

Mit neuen und bahnbrechenden Technologien, die den Status quo ständig hinterfragen, schreitet die Gesundheitsbranche sprunghaft voran. Aber in einer Branche, die auf Vorschriften basiert, sind strategische Partnerschaften oft der Schlüssel für eine erfolgreiche Geschäftsentwicklung.

Unsere leidenschaftlichen Berater, unterstützt von Subbranchenteams weltweit, nutzen ihr fundiertes Fachwissen, um Ihren Wettbewerbsvorteil zu finden, die lokalen Gewohnheiten zu verstehen und Ihnen bei der Entwicklung der am besten geeigneten Strategie zu unterstützen.

Ansprechpartner

Global

556

abgeschlossene Transaktionen in der Gesundheitswesen

Global

Informieren Sie sich über alle unsere branchenbezogenen Transaktionen

Zu den Deals

Banook, backed by Motion Equity, has acquired Fluidda

Gesundheitswesen | Technologie, Medien und Telekommunikation

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

Weitere Informationen

Iason GmbH has continued its refinancing efforts with local banks based on an IBR

Gesundheitswesen

Iason GmbH has continued its refinancing efforts with local banks based on an IBR

The shareholders of Iason GmbH have completed a restructuring of the company and its refinancing efforts with local banks based on an IBR.

Weitere Informationen

Röntgeninstitut Aarau has been acquired by Evidia

Gesundheitswesen

Röntgeninstitut Aarau has been acquired by Evidia

The owners of Röntgeninstitut Aarau have sold the business to Evidia Group as part of their succession planning. The former owners will remain involved in the institute and support its future development alongside Evidia.

Weitere Informationen

„Oaklins’ efforts enabled us to join Banook and significantly enhance our impact on respiratory drug development. Together with an outstanding transaction team, we were able to efficiently integrate into the Banook platform, backed by Motion Equity Partners.“

Jan De Backer

CEO, Fluidda NV

Weitere Information

Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Growth and continuity shape Q3 transactions

QUARTERLY M&A ACTIVITY: In Q3 2026, Oaklins clients closed 67 deals across M&A and fundraising, with buyers seeking expertise, customer relationships and new market access.

Weitere Informationen